Ledger.Open graph →
SEC Form D · filed March 21, 2013

Reviva Pharmaceuticals, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
—
Industry
Pharmaceuticals
Location
SAN JOSE, CA
Type
—

People & firms on this filing (2)

Laxminarayan Bhat · SAN JOSE, CAExec · DirectorLaxminarayan Bhat · Santa Clara, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗